INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)
$15.31 0.1 (0.6575%)
Analysed INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) News Sources
Intellia Therapeutics, Inc. (NTLA) Sees Moderate Buy Rating From Analysts
21-04-2026
yahoo.com
NTLA Stock Rises 20% in 3 Months: Here's What You Should Know
16-04-2026
yahoo.com
2 Healthcare Stocks to Buy and 1 to Approach With Caution
15-04-2026
fool.com
How The Narrative On Intellia Therapeutics (NTLA) Is Shifting After MAGNITUDE Hold Resolution
13-04-2026
yahoo.com
Colossal’s Ben Lamm Says Invasive Species Is a $5.4 Trillion Problem. Here’s His Solution
12-04-2026
247wallst.com
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03-04-2026
yahoo.com
Take the Zacks Approach to Beat the Markets: LiveOne, Micron, Clorox in Focus
23-03-2026
yahoo.com
This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy?
08-03-2026
fool.com
A Look At Intellia Therapeutics (NTLA) Valuation After Its Recent Share Price Rebound
05-03-2026
yahoo.com
Roblox initiated, Target upgraded: Wall Street's top analyst calls
04-03-2026
yahoo.com
What is the current price of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The current price of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is $15.31.
INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) absolute price change since previous trading day?
The absolute price change of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) since the previous trading day is $0.1.
INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) percentage price change since previous trading day?
The percentage price change of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) since the previous trading day is 0.6575%.
What is the most recent average sentiment score for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The most recent average sentiment score for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The most recent sentiment for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is .
SEC-8K** Filing Available For INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.